Legacy Financial Advisors, Inc.

Position in IBRX — ImmunityBio, Inc.

CIK 1730810 COVINGTON, KY

Position in IBRX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$711,168

+$92,583 QoQ

Shares Held

81,230

+0.7% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#132

of 401 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Legacy Financial Advisors, Inc. holds $3,774,599 across 5 Biotechnology names. IBRX ranks #3 (18.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,139	$1,559,235
2	REGN	Regeneron Pharmaceuticals, Inc.	1,438	$896,650
3	IBRX	ImmunityBio, Inc. This page	81,230	$711,168
4	INCY	Incyte Corp	3,093	$350,622
5	EXEL	Exelixis, Inc.	4,722	$256,924

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$711,168	81,230	+0.7%	Shares	Sole	2026-08-05
2026-03-31	$618,585	80,650	+5.2%	Shares	Sole	2026-04-30
2025-12-31	$151,767	76,650	+69.4%	Shares	Sole	2026-02-04
2025-09-30	$111,315	45,250	—	Shares	Sole	2025-11-10
No filing history on record for this holder in this stock.